Tunable, biodegradable gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging

Biomaterials

Volumn 102, Issue , 2016, Pages 87-97

  Cheheltani, Rabee ^a   Ezzibdeh, Rami M ^a   Chhour, Peter ^b   Pulaparthi, Kumidini ^a   Kim, Johoon ^b   Jurcova, Martina ^a   Hsu, Jessica C ^b   Blundell, Cassidy ^b   Litt, Harold I ^a   Ferrari, Victor A ^a   Allcock, Harry R ^c   Sehgal, Chandra M ^a   Cormode, David P ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Computed tomography; Contrast agent; Gold nanoparticle; Metal polymer nanoparticle; Photoacoustic imaging

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABILITY; BYPRODUCTS; CARDIOVASCULAR SYSTEM; COMPUTERIZED TOMOGRAPHY; FIBER OPTIC SENSORS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; INFRARED DEVICES; METAL NANOPARTICLES; NANOPARTICLES; PHOTOACOUSTIC EFFECT; PHYSIOLOGY; SYNTHESIS (CHEMICAL); TOMOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY;

BLOOD CIRCULATION; CONTRAST AGENT; GOLD NANOPARTICLES; METAL POLYMERS; MICRO-FLUIDIC DEVICES; NANOPARTICLE SIZES; NEAR INFRARED REGION; PHOTO-ACOUSTIC IMAGING;

GOLD;

CONTRAST MEDIUM; COPOLYMER; GOLD NANOPARTICLE; GOLD POLY DI(CARBOXYLATOPHENOXY)PHOSPHAZENE NANOPARTICLE; MACROGOL; NANOSPHERE; POLYLYSINE; POLYMER; UNCLASSIFIED DRUG; GOLD; METAL NANOPARTICLE; ORGANOPHOSPHORUS COMPOUND; POLY(DI(CARBOXYLATOPHENOXY)PHOSPHAZENE);

ABSORPTION; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING EQUIPMENT; DRUG POTENCY; EVALUATION STUDY; EXCRETION; HUMAN; HUMAN CELL; IMAGING SOFTWARE; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MOUSE; NANOENCAPSULATION; NANOIMAGING; NONHUMAN; PARTICLE SIZE; PHOTOACOUSTICS; PRIORITY JOURNAL; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; PROCEDURES; ULTRASTRUCTURE; X-RAY COMPUTED TOMOGRAPHY;

ANIMALS; CELL LINE; CONTRAST MEDIA; GOLD; HUMANS; METAL NANOPARTICLES; MICE, INBRED C57BL; ORGANOPHOSPHORUS COMPOUNDS; PHOTOACOUSTIC TECHNIQUES; POLYMERS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84975526934     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.06.015     Document Type: Article

References (52)

1. [1] Cormode, D.P., Skajaa, T., Fayad, Z.A., Mulder, W.J.M., Nanotechnology in medical imaging: probe design and applications. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 992–1000.
2. [2] Kircher, M.F., Willmann, J.K., Molecular body imaging: MR imaging, CT, and US. Part I. Princ. Radiol. 263 (2012), 633–643.
3. [3] Jokerst, J.V., Lobovkina, T., Zare, R.N., Gambhir, S.S., Nanoparticle PEGylation for imaging and therapy. Nanomed. (Lond.). 6 (2011), 715–728.
4. [4] Thaxton, C.S., Rink, J.S., Naha, P.C., Cormode, D.P., Lipoproteins and lipoprotein mimetics for imaging and drug delivery. Adv. Drug Deliv. Rev., 2016.
5. [5] Shapiro, E.M., Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking. Magn. Reson. Med. 73 (2015), 376–389.
6. [6] Louie, A., Multimodality imaging probes: design and challenges. Chem. Rev. 110 (2010), 3146–3195.
7. [7] Mieszawska, A.J., Mulder, W.J.M., Fayad, Z.A., Cormode, D.P., Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol. Pharm. 10 (2013), 831–847.
8. [8] Thakor, A.S., Jokerst, J., Zavaleta, C., Massoud, T.F., Gambhir, S.S., Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett. 11 (2011), 4029–4036.
9. [9] Naha, P.C., Chhour, P., Cormode, D.P., Systematic in vitro toxicological screening of gold nanoparticles designed for nanomedicine applications. Toxicol. In Vitro 29 (2015), 1445–1453.
10. [10] Cormode, D.P., Roessl, E., Thran, A., Skajaa, T., Gordon, R.E., Schlomka, J.-P., Fuster, V., Fisher, E.A., Mulder, W.J.M., Proksa, R., et al. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology 256 (2010), 774–782.
11. [11] Cormode, D.P., Skajaa, T., van Schooneveld, M.M., Koole, R., Jarzyna, P., Lobatto, M.E., Calcagno, C., Barazza, A., Gordon, R.E., Zanzonico, P., et al. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett. 8 (2008), 3715–3723.
12. [12] Galper, M.W., Saung, M.T., Fuster, V., Roessl, E., Thran, A., Proksa, R., Fayad, Z.A., Cormode, D.P., Effect of computed tomography scanning parameters on gold nanoparticle and iodine contrast. Investig. Radiol. 47 (2012), 475–481.
13. [13] Cai, Q.-Y., Kim, S.H., Choi, K.S., Kim, S.Y., Byun, S.J., Kim, K.W., Park, S.H., Juhng, S.K., Yoon, K.-H., Colloidal gold nanoparticles as a blood-pool contrast agent for x-ray computed tomography in mice. Investig. Radiol. 42 (2007), 797–806.
14. [14] Arifin, D.R., Long, C.M., Gilad, A.A., Alric, C., Roux, S., Tillement, O., Link, T.W., Arepally, A., Bulte, J.W.M., Trimodal gadolinium-gold microcapsules containing pancreatic islet cells restore normoglycemia in diabetic mice and can Be tracked by using US, CT, and positive-contrast MR imaging. Radiology 260 (2011), 790–798.
15. [15] Jackson, P.A., Rahman, W.N.W.A., Wong, C.J., Ackerly, T., Geso, M., Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents. Eur. J. Radiol. 75 (2010), 104–109.
16. [16] Stacul, F., van der Molen, A.J., Reimer, P., Webb, J.A.W., Thomsen, H.S., Morcos, S.K., Almén, T., Aspelin, P., Bellin, M.-F., Clement, O., et al. Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur. Radiol. 21 (2011), 2527–2541.
17. [17] Li, W., Chen, X., Gold nanoparticles for photoacoustic imaging. Nanomedicine 10 (2015), 299–320.
18. [18] Jing, L., Liang, X., Deng, Z., Feng, S., Li, X., Huang, M., Li, C., Dai, Z., Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Biomaterials 35 (2014), 5814–5821.
19. [19] Raghavan, V., Subhash, H., Breathnach, A., Leahy, M., Dockery, P., Olivo, M., Dual plasmonic gold nanoparticles for multispectral photoacoustic imaging application. Proc. SPIE 8943, Photons Plus Ultrasound: Imaging and Sensing, 8943, 2014, 89434J.
20. [20] Yoon, S.J., Mallidi, S., Tam, J.M., Tam, J.O., Murthy, A., Johnston, K.P., Sokolov, K.V., Emelianov, S.Y., Utility of biodegradable plasmonic nanoclusters in photoacoustic imaging. Opt. Lett. 35 (2010), 3751–3753.
21. [21] Libutti, S.K., Paciotti, G.F., Byrnes, A.A., Alexander, H.R., Gannon, W.E., Walker, M., Seidel, G.D., Yuldasheva, N., Tamarkin, L., Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res. 16 (2010), 6139–6149.
22. [22] Wu, X., Ming, T., Wang, X., Wang, P., Wang, J., Chen, J., High-photoluminescence-yield gold nanocubes: for cell imaging and photothermal therapy. ACS Nano 4 (2010), 113–120.
23. [23] Qian, X., Peng, X.-H., Ansari, D.O., Yin-Goen, Q., Chen, G.Z., Shin, D.M., Yang, L., Young, A.N., Wang, M.D., Nie, S., Vivo tumor targeting and spectroscopic detection with surface-enhanced raman nanoparticle tags. Nat. Biotechnol. 26 (2007), 83–90.
24. [24] van Schooneveld, M.M., Cormode, D.P., Koole, R., van Wijngaarden, J.T., Calcagno, C., Skajaa, T., Hilhorst, J., Hart, D. C. 't, Fayad, Z.A., Mulder, W.J.M., et al. A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging. Contrast Media Mol. Imaging 5 (2010), 231–236.
25. [25] Choi, H.S., Liu, W., Misra, P., Tanaka, E., Zimmer, J.P., Itty Ipe, B., Bawendi, M.G., Frangioni, J.V., Renal clearance of quantum dots. Nat. Biotechnol. 25 (2007), 1165–1170.
26. [26] Fitzpatrick, J.A.J., Andreko, S.K., Ernst, L.A., Waggoner, A.S., Ballou, B., Bruchez, M.P., Long-term persistence and spectral blue shifting of quantum dots in vivo. Nano Lett. 9 (2009), 2736–2741.
27. [27] Sadauskas, E., Danscher, G., Stoltenberg, M., Vogel, U., Larsen, A., Wallin, H., Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 5 (2009), 162–169.
28. [28] Hainfeld, J.F., Slatkin, D.N., Focella, T.M., Smilowitz, H.M., Gold nanoparticles: a new x-ray contrast agent. Br. J. Radiol. 79 (2006), 248–253.
29. [29] Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
30. [30] Huang, P., Lin, J., Li, W., Rong, P., Wang, Z., Wang, S., Wang, X., Sun, X., Aronova, M., Niu, G., et al. Biodegradable gold nanovesicles with an ultrastrong plasmonic coupling effect for photoacoustic imaging and photothermal therapy. Angew. Chem. Int. Ed. Engl. 52 (2013), 13958–13964.
31. [31] Tam, J.M., Tam, J.O., Murthy, A., Ingram, D.R., Ma, L.L., Travis, K., Johnston, K.P., Sokolov, K.V., Controlled assembly of biodegradable plasmonic nanoclusters for near-infrared imaging and therapeutic applications. ACS Nano 4 (2010), 2178–2184.
32. [32] Kumbar, S.G., Bhattacharyya, S., Nukavarapu, S.P., Khan, Y.M., Nair, L.S., Laurencin, C.T., In vitro and in vivo characterization of biodegradable poly(organophosphazenes) for biomedical applications. J. Inorg. Organomet. Polym. Mater. 16 (2006), 365–385.
33. [33] Allcock, H.R., Morozowich, N.L., Bioerodible polyphosphazenes and their medical potential. Polym. Chem., 3, 2012, 578.
34. [34] Andrianov, A., Protein release from polyphosphazene matrices. Adv. Drug Deliv. Rev. 31 (1998), 185–196.
35. [35] Andrianov, A.K., Payne, L.G., Visscher, K.B., Allcock, H.R., Langer, R., Hydrolytic degradation of ionically cross-linked polyphosphazene microspheres. J. Appl. Polym. Sci. 53 (1994), 1573–1578.
36. [36] Andrianov, A.K., Marin, A., Degradation of polyaminophosphazenes: effects of hydrolytic environment and polymer processing. Biomacromolecules 7 (2006), 1581–1586.
37. [37] Turkevich, J., Stevenson, P.C., Hillier, J., A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc., 11, 1951, 55.
38. [38] Low, A., Bansal, V., A visual tutorial on the synthesis of gold nanoparticles. Biomed. Imaging Interv. J., 6, 2010, e9.
39. [39] Bohndiek, S.E., Bodapati, S., Van De Sompel, D., Kothapalli, S.-R., Gambhir, S.S., Development and application of stable phantoms for the evaluation of photoacoustic imaging instruments. PLoS One, 8, 2013, e75533.
40. [40] Simpson, C.A., Salleng, K.J., Cliffel, D.E., Feldheim, D.L., In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomedicine 9 (2013), 257–263.
41. [41] Zhou, C., Long, M., Qin, Y., Sun, X., Zheng, J., Luminescent gold nanoparticles with efficient renal clearance. Angew. Chem. 123 (2011), 3226–3230.
42. [42] Vinluan, R.D., Liu, J., Zhou, C., Yu, M., Yang, S., Kumar, A., Sun, S., Dean, A., Sun, X., Zheng, J., Glutathione-coated luminescent gold nanoparticles: a surface ligand for minimizing serum protein adsorption. ACS Appl. Mater. Interfaces 6 (2014), 11829–11833.
43. [43] Yu, M., Zheng, J., Clearance pathways and tumor targeting of imaging nanoparticles. ACS Nano 9 (2015), 6655–6674.
44. [44] Chhour, P., Gallo, N., Cheheltani, R., Williams, D., Al-Zaki, A., Paik, T., Nichol, J.L., Tian, Z., Naha, P.C., Witschey, W.R., et al. Nanodisco balls: control over surface versus core loading of diagnostically active nanocrystals into polymer nanoparticles. ACS Nano 8 (2014), 9143–9153.
45. [45] Stroock, A.D., Dertinger, S.K.W., Ajdari, A., Mezic, I., Stone, H.A., Whitesides, G.M., Chaotic mixer for microchannels. Science 295 (2002), 647–651 (80-. ).
46. [46] Saha, K., Agasti, S.S., Kim, C., Li, X., Rotello, V.M., Gold nanoparticles in chemical and biological sensing. Chem. Rev. 112 (2012), 2739–2779.
47. [47] Orza, A., Yang, Y., Feng, T., Wang, X., Wu, H., Li, Y., Yang, L., Tang, X., Mao, H., A nanocomposite of Au-AgI core/shell dimer as a dual-modality contrast agent for x-ray computed tomography and photoacoustic imaging. Med. Phys. 43 (2016), 589–599.
48. [48] Gilbert, P.B., Chiu, Y.-L., Allen, M., Lawrence, D.N., Chapdu, C., Israel, H., Holman, D., Keefer, M.C., Wolff, M., Frey, S.E., Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored phase I and II clinical trials. Vaccine 21 (2003), 2933–2947.
49. [49] Thongcharoen, P., Suriyanon, V., Paris, R.M., Khamboonruang, C., de Souza, M.S., Ratto-Kim, S., Karnasuta, C., Polonis, V.R., Baglyos, L., Habib, R. El, et al. A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost. J. Acquir. Immune Defic. Syndr. 46 (2007), 48–55.
50. [50] Bouveret Le Cam, N.N., Ronco, J., Francon, A., Blondeau, C., Fanget, B., Adjuvants for influenza vaccine. Res. Immunol. 149 (1998), 19–23.
51. [51] Unverdorben, M., Degenhardt, R., Sick, P., Kastrati, A., Desmet, W., Colombo, A., Garcia, E., Klein, W., Wagner, E., Köhler, H., et al. Evaluation of the coroflex theca-stent for reduction of restenosis (ECORI). J. Invasive Cardiol. 17 (2005), 199–202.
52. [52] Corot, C., Robert, P., Idee, J., Port, M., Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 58 (2006), 1471–1504.